An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.

Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.